Bausch Health Companies BHC International — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's international — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch Health Companies's international — revenue?
- Bausch Health Companies (BHC) reported international — revenue of $285M in Q1 2026.
- How has Bausch Health Companies's international — revenue changed year-over-year?
- Bausch Health Companies's international — revenue increased by 8.8% year-over-year, from $262M to $285M.
- What is the long-term trend for Bausch Health Companies's international — revenue?
- Over 4 years (2021 to 2025), Bausch Health Companies's international — revenue has grown at a -0.7% compound annual growth rate (CAGR), from $1.17B to $1.13B.
- What does international — revenue mean?
- The total gross revenue generated from the sale of pharmaceutical products and services within the international business segment. This metric represents the top-line performance of the company's global operations outside of primary domestic markets. It is a key indicator of market demand and the effectiveness of the international commercial strategy.